β-lactam resistance in methicillin-resistant Staphylococcus aureus USA300 is increased by inactivation of the ClpXP protease

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 8, 2014, Pages 4593-4603

  Bæk, Kristoffer T ^a   Gründling, Angelika ^b   Mogensen, René G ^a   Thøgersen, Louise ^a   Petersen, Andreas ^c   Paulander, Wilhelm ^a   Frees, Dorte ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAM; ENDOPEPTIDASE CLP; ISOENZYME; MECA PROTEIN, STAPHYLOCOCCUS AUREUS; N ACETYLMURAMOYLALANINE AMIDASE; PENICILLIN BINDING PROTEIN; PEPTIDOGLYCAN;

ANTIBIOTIC RESISTANCE; CELL WALL; DEFICIENCY; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUTATION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMS; CELL WALL; ENDOPEPTIDASE CLP; GENE EXPRESSION REGULATION, BACTERIAL; ISOENZYMES; METABOLIC NETWORKS AND PATHWAYS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MUTATION; N-ACETYLMURAMOYL-L-ALANINE AMIDASE; PENICILLIN-BINDING PROTEINS; PEPTIDOGLYCAN;

EID: 84905366993     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02802-14     Document Type: Article

References (77)

1. DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. 2010. Communityassociated meticillin-resistant Staphylococcus aureus. Lancet 375:1557-1568. http://dx.doi.org/10.1016/S0140-6736(09)61999-1.
2. Graveland H, Duim B, van Duijkeren E, Heederik D, Wagenaar J. 2011. Livestock-associated methicillin-resistant Staphylococcus aureus in animals and humans. Int. J. Med. Microbiol. 301:630-634. http://dx.doi.org/10.1016/j.ijmm. 2011.09.004.
3. Otto M. 2010. Basis of virulence in community-associated methicillinresistant Staphylococcus aureus. Annu. Rev. Microbiol. 64:143-162. http://dx.doi.org/10.1146/annurev.micro.112408.134309.
4. Hartman B, Tomasz A. 1984. Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J. Bacteriol. 158:513-516.
5. Pinho M, de Lencastre H, Tomasz A. 2001. An acquired and a native penicillin-binding protein cooperate in building the cell wall of drugresistant staphylococci. Proc. Natl. Acad. Sci. U. S. A. 98:10886-10891. http://dx.doi.org/10.1073/pnas.191260798.
6. Chambers HF, Sachdeva MJ, Hackbarth CJ. 1994. Kinetics of penicillin binding to penicillin-binding proteins of Staphylococcus aureus. Biochem. J. 301(Pt 1):139-144.
7. Lu WP, Sun Y, Bauer MD, Paule S, Koenigs PM, Kraft WG. 1999. Penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus: kinetic characterization of its interactions with beta-lactams using electrospray mass spectrometry. Biochemistry (Wash.) 38:6537-6546. http://dx.doi.org/10.1021/bi990025e.
8. Parvez M, Shibata H, Nakano T, Niimi S, Fujii N, Arakaki N, Higuti T. 2008. No relationship exists between PBP 2a amounts expressed in different MRSA strains obtained clinically and their beta-lactam MIC values. J. Med. Invest. 55:246-253. http://dx.doi.org/10.2152/jmi.55.246.
9. Hososaka Y, Hanaki H, Endo H, Suzuki Y, Nagasawa Z, Otsuka Y, Nakae T, Sunakawa K. 2007. Characterization of oxacillin-susceptible mecA-positive Staphylococcus aureus: a new type of MRSA. J. Infect. Chemother. 13:79-86. http://dx.doi.org/10.1007/s10156-006-0502-7.
10. Murakami K, Tomasz A. 1989. Involvement of multiple genetic determinants in high-level methicillin resistance in Staphylococcus aureus. J. Bacteriol. 171:874-879.
11. Hartman B, Tomasz A. 1986. Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 29:85-92. http://dx.doi.org/10.1128/AAC.29.1.85.
12. Roemer T, Schneider T, Pinho M. 2013. Auxiliary factors: a chink in the armor of MRSA resistance to β-lactam antibiotics. Curr. Opin. Microbiol. 16:1-11. http://dx.doi.org/10.1016/j.mib.2013.03.001.
13. Berger-Bächi B, Rohrer S. 2002. Factors influencing methicillin resistance in staphylococci. Arch. Microbiol. 178:165-171. http://dx.doi.org/10. 1007/s00203-002-0436-0.
14. Leski T, Tomasz A. 2005. Role of penicillin-binding protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-linking of Staphylococcus aureus: evidence for the cooperative functioning of PBP2, PBP4, and PBP2A. J. Bacteriol. 187:1815-1824. http://dx.doi.org/10.1128/JB.187.5.1815-1824.2005.
15. Pinho M, Ludovice A, Wu S, De Lencastre H. 1997. Massive reduction in methicillin resistance by transposon inactivation of the normal PBP2 in a methicillin-resistant strain of Staphylococcus aureus. Microb. Drug Resist. 3:409-413. http://dx.doi.org/10.1089/mdr.1997.3.409.
16. Campbell J, Singh A, Santa Maria JP, Jr, Kim Y, Brown S, Swoboda J, Mylonakis E, Wilkinson B, Walker S. 2011. Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus. ACS Chem. Biol. 6:106-116. http://dx.doi.org/10.1021/cb100269f.
17. Maki H, Yamaguchi T, Murakami K. 1994. Cloning and characterization of a gene affecting the methicillin resistance level and the autolysis rate in Staphylococcus aureus. J. Bacteriol. 176:4993-5000.
18. Lee S, Jarantow L, Wang H, Sillaots S, Cheng H, Meredith T, Thompson J, Roemer T. 2011. Antagonism of chemical genetic interaction networks resensitize MRSA to β-lactam antibiotics. Chem. Biol. 18:1379-1389. http://dx.doi.org/10.1016/j.chembiol.2011.08.015.
19. Memmi G, Filipe S, Pinho M, Fu Z, Cheung A. 2008. Staphylococcus aureus PBP4 is essential for beta-lactam resistance in communityacquired methicillin-resistant strains. Antimicrob. Agents Chemother. 52:3955-3966. http://dx.doi.org/10.1128/AAC.00049-08.
20. Atilano M, Pereira P, Yates J, Reed P, Veiga H, Pinho M, Filipe S. 2010. Teichoic acids are temporal and spatial regulators of peptidoglycan crosslinking in Staphylococcus aureus. Proc. Natl. Acad. Sci. U. S. A. 107:18991-18996. http://dx.doi.org/10.1073/pnas.1004304107.
21. Farha M, Leung A, Sewell E, D'Elia M, Allison S, Ejim L, Pereira P, Pinho M, Wright G, Brown E. 2013. Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to β-lactams. ACS Chem. Biol. 8:226-233. http://dx.doi.org/10.1021/cb300413m.
22. Tan CM, Therien AG, Lu J, Lee SH, Caron A, Gill CJ, Lebeau-Jacob C, Benton-Perdomo L, Monteiro JM, Pereira PM, Elsen NL, Wu J, Deschamps K, Petcu M, Wong S, Daigneault E, Kramer S, Liang L, Maxwell E, Claveau D, Vaillancourt J, Skorey K, Tam J, Wang H, Meredith TC, Sillaots S, Wang-Jarantow L, Ramtohul Y, Langlois E, Landry F, Reid JC, Parthasarathy G, Sharma S, Baryshnikova A, Lumb KJ, Pinho MG, Soisson SM, Roemer T. 2012. Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics. Sci. Transl. Med. 4:126ra135. http://dx.doi.org/10.1126/scitranslmed.3003592.
23. Wang H, Gill CJ, Lee SH, Mann P, Zuck P, Meredith TC, Murgolo N, She X, Kales S, Liang L, Liu J, Wu J, Santa Maria J, Su J, Pan J, Hailey J, McGuinness D, Tan CM, Flattery A, Walker S, Black T, Roemer T. 2013. Discovery of wall teichoic acid inhibitors as potential anti-MRSA β-lactam combination agents. Chem. Biol. 20:272-284. http://dx.doi.org/10.1016/j.chembiol.2012.11. 013.
24. Frees D, Brøndsted L, Ingmer H. 2013. Bacterial proteases and virulence. Subcell. Biochem. 66:161-192. http://dx.doi.org/10.1007/978-94-007- 5940-4-7.
25. Frees D, Qazi SN, Hill P, Ingmer H. 2003. Alternative roles of ClpX and ClpP in Staphylococcus aureus stress tolerance and virulence. Mol. Microbiol. 48:1565-1578. http://dx.doi.org/10.1046/j.1365-2958.2003.03524.x.
26. Farrand AJ, Reniere ML, Ingmer H, Frees D, Skaar EP. 2013. Regulation of host hemoglobin binding by the Staphylococcus aureus Clp proteolytic system. J. Bacteriol. 195:5041-5050. http://dx.doi.org/10.1128/JB.00505-13.
27. Frees D, Savijoki K, Varmanen P, Ingmer H. 2007. Clp ATPases and ClpP proteolytic complexes regulate vital biological processes in low GC, Gram-positive bacteria. Mol. Microbiol. 63:1285-1295. http://dx.doi.org/10.1111/ j.1365-2958.2007.05598.x.
28. Wawrzynow A, Wojtkowiak D, Marszalek J, Banecki B, Jonsen M, Graves B, Georgopoulos C, Zylicz M. 1995. The ClpX heat-shock protein of Escherichia coli, the ATP-dependent substrate specificity component of the ClpP-ClpX protease, is a novel molecular chaperone. EMBO J. 14:1867-1877.
29. Shoji M, Cui L, Iizuka R, Komoto A, Neoh H, Watanabe Y, Hishinuma T, Hiramatsu K. 2011. walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus. Antimicrob. Agents Chemother. 55:3870-3881. http://dx.doi.org/10.1128/AAC.01563-10.
30. Peleg A, Miyakis S, Ward D, Earl A, Rubio A, Cameron D, Pillai S, Moellering RC, Jr, Eliopoulos G. 2012. Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus. PLoS One 7:e28316. http://dx.doi.org/10.1371/journal. pone.0028316.
31. Song Y, Rubio A, Jayaswal R, Silverman J, Wilkinson B. 2013. Additional routes to Staphylococcus aureus daptomycin resistance as revealed by comparative genome sequencing, transcriptional profiling, and phenotypic studies. PLoS One 8:e58469. http://dx.doi.org/10.1371/journal.pone.0058469.
32. Horton RM, Ho SN, Pullen JK, Hunt HD, Cai Z, Pease LR. 1993. Gene splicing by overlap extension. Methods Enzymol. 217:270-279. http://dx.doi.org/10.1016/0076-6879(93)17067-F.
33. Brückner R. 1997. Gene replacement in Staphylococcus carnosus and Staphylococcus xylosus. FEMS Microbiol. Lett. 151:1-8. http://dx.doi.org/10. 1016/S0378-1097(97)00116-X.
34. Renzoni A, Kelley WL, Barras C, Monod A, Huggler E, François P, Schrenzel J, Studer R, Vaudaux P, Lew DP. 2009. Identification by genomic and genetic analysis of two new genes playing a key role in intermediate glycopeptide resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 53:903-911. http://dx.doi.org/10.1128/AAC.01287-08.
35. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-9th ed. CLSI document M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
36. Jelsbak L, Ingmer H, Valihrach L, Cohn MT, Christiansen MH, Kallipolitis BH, Frees D. 2010. The chaperone ClpX stimulates expression of Staphylococcus aureus protein A by Rot dependent and independent pathways. PLoS One 5:e12752. http://dx.doi.org/10.1371/journal.pone.0012752.
37. Klitgaard JK, Skov MN, Kallipolitis BH, Kolmos HJ. 2008. Reversal of methicillin resistance in Staphylococcus aureus by thioridazine. J. Antimicrob. Chemother. 62:1215-1221. http://dx.doi.org/10.1093/jac/dkn417.
38. Sieradzki K, Villari P, Tomasz A. 1998. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillinresistant clinical isolates of staphylococci. Antimicrob. Agents Chemother. 42:100-107.
39. Corrigan RM, Abbott JC, Burhenne H, Kaever V, Gründling A. 2011. c-di-AMP is a new second messenger in Staphylococcus aureus with a role in controlling cell size and envelope stress. PLoS Pathog. 7:e1002217. http://dx.doi.org/10.1371/journal.ppat.1002217.
40. Zeileis A, Grothendieck G. 2005. zoo: S3 infrastructure for regular and irregular time series. J. Stat. Softw. 14:1-27. http://www.jstatsoft.org/v14/ i06/paper.
41. The R Core Team. 2013. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://web.mit.edu/r-v3.0.1/fullrefman.pdf.
42. Frees D, Chastanet A, Qazi S, Sørensen K, Hill P, Msadek T, Ingmer H. 2004. Clp ATPases are required for stress tolerance, intracellular replication and biofilm formation in Staphylococcus aureus. Mol. Microbiol. 54:1445-1462. http://dx.doi.org/10.1111/j.1365-2958.2004.04368.x.
43. Tomasz A, Nachman S, Leaf H. 1991. Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci. Antimicrob. Agents Chemother. 35:124-129. http://dx.doi.org/10.1128/AAC.35.1. 124.
44. de Jonge BL, Chang YS, Gage D, Tomasz A. 1992. Peptidoglycan composition of a highly methicillin-resistant Staphylococcus aureus strain. The role of penicillin binding protein 2A. J. Biol. Chem. 267:11248-11254.
45. Gustafson JE, Berger-Bächi B, Strässle A, Wilkinson BJ. 1992. Autolysis of methicillin-resistant and -susceptible Staphylococcus aureus. Antimicrob. Agents Chemother. 36:566-572. http://dx.doi.org/10.1128/AAC.36.3. 566.
46. Dengler V, McCallum N, Kiefer P, Christen P, Patrignani A, Vorholt J, Berger-Bächi B, Senn M. 2013. Mutation in the c-di-AMP cyclase dacA affects fitness and resistance of methicillin resistant Staphylococcus aureus. PLoS One 8:e73512. http://dx.doi.org/10.1371/journal.pone.0073512.
47. Kajimura J, Fujiwara T, Yamada S, Suzawa Y, Nishida T, Oyamada Y, Hayashi I, Yamagishi J, Komatsuzawa H, Sugai M. 2005. Identification and molecular characterization of anN-acetylmuramyl-L-alanine amidase Sle1 involved in cell separation of Staphylococcus aureus. Mol. Microbiol. 58:1087-1101. http://dx.doi.org/10.1111/j.1365-2958.2005.04881.x.
48. Feng J, Michalik S, Varming AN, Andersen JH, Albrecht D, Jelsbak L, Krieger S, Ohlsen K, Hecker M, Gerth U, Ingmer H, Frees D. 2013. Trapping and proteomic identification of cellular substrates of the ClpP protease in Staphylococcus aureus. J. Proteome Res. 12:547-558. http://dx.doi.org/10.1021/ pr300394r.
49. Komatsuzawa H, Sugai M, Nakashima S, Yamada S, Matsumoto A, Oshida T, Suginaka H. 1997. Subcellular localization of the major autolysin, ATL and its processed proteins in Staphylococcus aureus. Microbiol. Immunol. 41:469-479. http://dx.doi.org/10.1111/j.1348-0421.1997.tb01880.x.
50. Oshida T, Sugai M, Komatsuzawa H, Hong Y, Suginaka H, Tomasz A. 1995. A Staphylococcus aureus autolysin that has an N-acetylmuramoyl-Lalanine amidase domain and an endo-beta-N-acetylglucosaminidase domain: cloning, sequence analysis, and characterization. Proc. Natl. Acad. Sci. U. S. A. 92:285-289. http://dx.doi.org/10.1073/pnas.92.1.285.
51. Kirstein J, Hoffmann A, Lilie H, Schmidt R, Rübsamen-Waigmann H, Brötz-Oesterhelt H, Mogk A, Turgay K. 2009. The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease. EMBO Mol. Med. 1:37-49. http://dx.doi.org/10.1002/emmm.200900002.
52. McGillivray SM, Tran DN, Ramadoss NS, Alumasa JN, Okumura CY, Sakoulas G, Vaughn MM, Zhang DX, Keiler KC, Nizet V. 2012. Pharmacological inhibition of the ClpXP protease increases bacterial susceptibility to host cathelicidin antimicrobial peptides and cell envelope-active antibiotics. Antimicrob. Agents Chemother. 56:1854-1861. http://dx.doi.org/10.1128/AAC.05131-11.
53. Yang SJ, Xiong YQ, Boyle-Vavra S, Daum R, Jones T, Bayer AS. 2010. Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillinresistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect"). Antimicrob. Agents Chemother. 54:3161-3169. http://dx.doi.org/10. 1128/AAC.00487-10.
54. Berti AD, Sakoulas G, Nizet V, Tewhey R, Rose WE. 2013. β-Lactam antibiotics targeting PBP1 selectively enhance daptomycin activity against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 57:5005-5012. http://dx.doi.org/10.1128/AAC.00594-13.
55. Nakao A, Imai S, Takano T. 2000. Transposon-mediated insertional mutagenesis of the D-alanyl-lipoteichoic acid (dlt) operon raises methicillin resistance in Staphylococcus aureus. Res. Microbiol. 151:823-829. http://dx.doi.org/10.1016/S0923-2508(00)01148-7.
56. Brown S, Xia G, Luhachack L, Campbell J, Meredith T, Chen C, Winstel V, Gekeler C, Irazoqui J, Peschel A, Walker S. 2012. Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids. Proc. Natl. Acad. Sci. U. S. A. 109:18909-18914. http://dx.doi.org/10.1073/pnas.1209126109.
57. Fujimura T, Murakami K. 1997. Increase of methicillin resistance in Staphylococcus aureus caused by deletion of a gene whose product is homologous to lytic enzymes. J. Bacteriol. 179:6294-6301.
58. Griffiths J, O'Neill A. 2012. Loss of function of the gdpP protein leads to joint β-lactam/glycopeptide tolerance in Staphylococcus aureus. Antimicrob. Agents Chemother. 56:579-581. http://dx.doi.org/10.1128/AAC.05148- 11.
59. Corrigan RM, Gründling A. 2013. Cyclic di-AMP: another second messenger enters the fray. Nat. Rev. Microbiol. 11:513-524. http://dx.doi.org/ 10.1038/nrmicro3069.
60. Pozzi C, Waters EM, Rudkin JK, Schaeffer CR, Lohan AJ, Tong P, Loftus BJ, Pier GB, Fey PD, Massey RC, O'Gara JP. 2012. Methicillin resistance alters the biofilm phenotype and attenuates virulence in Staphylococcus aureus device-associated infections. PLoS Pathog. 8:e1002626. http://dx.doi.org/10. 1371/journal.ppat.1002626.
61. Kim C, Mwangi M, Chung M, Milheirço C, de Lencastre H, Tomasz A. 2013. The mechanism of heterogeneous beta-lactam resistance in MRSA: key role of the stringent stress response. PLoS One 8:e82814. http://dx.doi.org/10.1371/ journal.pone.0082814.
62. Yang Y, Bhachech N, Bush K. 1995. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillinbinding proteins, and stability to hydrolysis by beta-lactamases. J. Antimicrob. Chemother. 35:75-84. http://dx.doi.org/10.1093/jac/35.1.75.
63. Dumitrescu O, Choudhury P, Boisset S, Badiou C, Bes M, Benito Y, Wolz C, Vandenesch F, Etienne J, Cheung AL, Bowden MG, Lina G. 2011. Beta-lactams interfering with PBP1 induce Panton-Valentine leukocidin expression by triggering sarA and rot global regulators of Staphylococcus aureus. Antimicrob. Agents Chemother. 55:3261-3271. http://dx.doi.org/10.1128/AAC.01401-10.
64. Frees D, Andersen JH, Hemmingsen L, Koskenniemi K, Bæk KT, Muhammed MK, Gudeta DD, Nyman TA, Sukura A, Varmanen P, Savijoki K. 2012. New insights into Staphylococcus aureus stress tolerance and virulence regulation from an analysis of the role of the ClpP protease in the strains Newman, COL, and SA564. J. Proteome Res. 11:95-108. http://dx.doi.org/10.1021/pr200956s.
65. Snowden MA, Perkins HR. 1990. Peptidoglycan cross-linking in Staphylococcus aureus. An apparent random polymerisation process. Eur. J. Biochem. 191:373-377.
66. Wyke AW, Ward JB, Hayes MV, Curtis NA. 1981. A role in vivo for penicillin-binding protein-4 of Staphylococcus aureus. Eur. J. Biochem. 119:389-393. http://dx.doi.org/10.1111/j.1432-1033.1981.tb05620.x.
67. Sieradzki K, Pinho MG, Tomasz A. 1999. Inactivated pbp4 in highly glycopeptideresistant laboratory mutants of Staphylococcus aureus. J. Biol. Chem. 274:18942-18946. http://dx.doi.org/10.1074/jbc.274.27.18942.
68. Katayama Y, Zhang HZ, Chambers HF. 2003. Effect of disruption of Staphylococcus aureus PBP4 gene on resistance to beta-lactam antibiotics. Microb. Drug Resist. 9:329-336. http://dx.doi.org/10.1089/107662903322762752.
69. Fuda C, Hesek D, Lee M, Morio K, Nowak T, Mobashery S. 2005. Activation for catalysis of penicillin-binding protein 2a from methicillinresistant Staphylococcus aureus by bacterial cell wall. J. Am. Chem. Soc. 127:2056-2057. http://dx.doi.org/10.1021/ja0434376.
70. Villegas-Estrada A, Lee M, Hesek D, Vakulenko SB, Mobashery S. 2008. Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics. J. Am. Chem. Soc. 130:9212-9213. http://dx.doi.org/10.1021/ja8029448.
71. Otero LH, Rojas-Altuve A, Llarrull LI, Carrasco-López C, Kumarasiri M, Lastochkin E, Fishovitz J, Dawley M, Hesek D, Lee M, Johnson JW, Fisher JF, Chang M, Mobashery S, Hermoso JA. 2013. How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function. Proc. Natl. Acad. Sci. U. S. A. 110:16808-16813. http://dx.doi.org/10.1073/pnas.1300118110.
72. Banerjee R, Gretes M, Basuino L, Strynadka N, Chambers HF. 2008. In vitro selection and characterization of ceftobiprole-resistant methicillinresistant Staphylococcus aureus. Antimicrob. Agents Chemother. 52:2089-2096. http://dx.doi.org/10.1128/AAC.01403-07.
73. Bæk KT, Frees D, Renzoni A, Barras C, Rodriguez N, Manzano C, Kelley WL. 2013. Genetic variation in the Staphylococcus aureus 8325 strain lineage revealed by whole-genome sequencing. PLoS One 8:e77122. http://dx.doi.org/10.1371/journal.pone.0077122.
74. Somerville GA, Beres SB, Fitzgerald JR, DeLeo FR, Cole RL, Hoff JS, Musser JM. 2002. In vitro serial passage of Staphylococcus aureus: changes in physiology, virulence factor production, and agr nucleotide sequence. J. Bacteriol. 184:1430-1437. http://dx.doi.org/10.1128/JB.184.5.1430-1437.2002.
75. Fey PD, Endres JL, Yajjala VK, Widhelm TJ, Boissy RJ, Bose JL, Bayles KW. 2013. A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes. mBio 4(1):e00537-12. http://dx.doi.org/10.1128/mBio.00537-12.
76. Dyke KG, Jevons MP, Parker MT. 1966. Penicillinase production and intrinsic resistance to penicillins in Staphylococcus aureus. Lancet i:835-838.
77. Gründling A, Schneewind O. 2007. Genes required for glycolipid synthesis and lipoteichoic acid anchoring in Staphylococcus aureus. J. Bacteriol. 189:2521-2530. http://dx.doi.org/10.1128/JB.01683-06.